Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib for Hypertrophic Cardiomyopathy in RASopathies
NCT06555237Phase 2Recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Aug 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in hypertrophic cardiomyopathy (HCM), Noonan syndrome, sponsored by Medical University of Warsaw. Started Aug 2024; status: recruiting.
02
Drugs
trametinib
03
Conditions
hypertrophic cardiomyopathy (HCM)Noonan syndrome
Beyond the preview
Go deeper on NCT06555237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06555237.